An intermediate vascular tumour between kaposiform hemangioendothelioma and tufted angioma with regression of the skin lesion

2017 ◽  
Vol 27 (2) ◽  
pp. 175-176 ◽  
Author(s):  
Teruhiko Makino ◽  
Waka Ishida ◽  
Takeru Hamashima ◽  
Megumi Mizawa ◽  
Masakiyo Sasahara ◽  
...  
2018 ◽  
Vol 29 (05) ◽  
pp. 401-407 ◽  
Author(s):  
Wei Yao ◽  
Kai Li ◽  
Zuopeng Wang ◽  
Jiahao Pei ◽  
Xiangqi Liu ◽  
...  

Objective To evaluate the outcome and safety of corticosteroids and vincristine (VCR) in the treatment of kaposiform hemangioendothelioma (KHE) and tufted angioma (TA). Materials and Methods Clinical studies involving corticosteroids and VCR therapies in treating KHE/TA were identified by using PubMed, Cochrane Library, OVID, EBSCO, CNKI, VIP, and Wanfang databases from their establishment date to December 2017. Randomized controlled trials, case–control, or case series with more than five cases were included. The following data were extracted: study sample, demographics, responses rate, recurrence rate, and adverse reactions. Two reviewers completed screening and extraction. Methodological quality was evaluated with quality appraisal tool. Results A total of 266 studies were found, and 27 studies were finally included in this research; quality of all studies was low. Seven studies with a total of 123 participants, which compared the effect of systemic corticosteroids with that of VCR, were performed for the meta-analysis. The results indicated that the effect of VCR was significantly higher than that of corticosteroids (relative risk [RR] = 2.08, 95% confidence interval [CI]: 1.38–3.16). The recurrence rate of VCR (11.1%) was lower than that of corticosteroids (50%), but there was no statistical difference between the two therapies (p = 0.1312). The result of pooled adverse reactions response rate for VCR was 18.2%, significantly lower than that for corticosteroids, which was 52.0%. Conclusion The present profile shows that VCR is relatively more effective and safer in treating KHE/TA than corticosteroids are. So, we believe VCR could be used as a first-line medication agent in the treatment of KHE/TA.


Dermatology ◽  
2003 ◽  
Vol 206 (4) ◽  
pp. 334-337 ◽  
Author(s):  
Chia-Yu Chu ◽  
Cheng-Hsiang Hsiao ◽  
Hsien-Ching Chiu

Medicine ◽  
2016 ◽  
Vol 95 (20) ◽  
pp. e3431 ◽  
Author(s):  
Xiaohan Liu ◽  
Jiaying Li ◽  
Xinhua Qu ◽  
Weili Yan ◽  
Ling Zhang ◽  
...  

2020 ◽  
Vol 44 ◽  
pp. 151434 ◽  
Author(s):  
Roel W. Ten Broek ◽  
Christian Koelsche ◽  
Astrid Eijkelenboom ◽  
Thomas Mentzel ◽  
David Creytens ◽  
...  

2019 ◽  
Vol 23 (1) ◽  
Author(s):  
Denny Mathew ◽  
Nasreen Mahomed

Primary pancreatic tumours are a rare and unusual entity in children. In this article, we present the case of an 8-month-old girl who presented with obstructive jaundice. The differential diagnosis based on imaging studies was that of a pancreatic vascular neoplasm; however, with the laboratory evidence of Kasabach–Merritt phenomenon (KMP), this prompted the diagnosis of pancreatic kaposiform hemangioendothelioma. A core biopsy of the pancreatic mass was taken at laparotomy and confirmed this diagnosis. The pancreas is an exceedingly rare site of occurrence for this tumour, with only nine cases being published to date. The clinical, biochemical, imaging and pathological findings are discussed to highlight a rare and potentially life-threatening vascular tumour.


2006 ◽  
Vol 33 (7) ◽  
pp. 492-497 ◽  
Author(s):  
Eiichi Arai ◽  
Akira Kuramochi ◽  
Tetsuya Tsuchida ◽  
Masazumi Tsuneyoshi ◽  
Masayoshi Kage ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document